Sergi Ferré

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

90h-index25.1kcitations361works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(178), Adenosine and Purinergic Signaling(126), Neuroscience and Neuropharmacology Research(97), Neurotransmitter Receptor Influence on Behavior(89), Neuropeptides and Animal Physiology(69)

Publications361 total

Functional significance of opioid receptor homomers and heteromers
Nature Communications·2025· 2 citedOpen Access
Press Releases Shape Online Attention for Neuroscience Articles
2025Open Access
On the mechanisms of dopamine receptor agonists in restless legs syndrome
SLEEP·2025· 2 citedOpen Access
Methadone and morphine have equivalent analgesic but not reward potency in female mice
Addiction Neuroscience·2025Open Access
Progesterone attenuates the effects of cocaine on hypermobility and dopaminergic transmission in the nucleus accumbens
Neuropharmacology·2025
Misleading Labeling of S-Methadone as a Novel N-Methyl-D-Aspartate Receptor Antagonist
The Journal of Clinical Psychiatry·2025
Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer
Pharmacological Research·2025· 2 citedOpen Access
Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells
ACS Chemical Biology·2025· 1 citedOpen Access
Locomotor activity depends on β-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer
Pharmacological Research·2025· 1 citedOpen Access
Subclinical Augmentation in Relation to Previous Dopaminergic Treatment in Patients with Restless Legs Syndrome: A Post Hoc Analysis of Two Randomized, Placebo-Controlled, Crossover Trials
CNS Drugs·2025· 3 cited
Investigating the Role for Galanin Signaling in Modulating Opioid Reward (Abstract ID: 169717)
Journal of Pharmacology and Experimental Therapeutics·2025
Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB<sub>1</sub> and Serotonin 5HT<sub>2A</sub> Receptors
Journal of Medicinal Chemistry·2024· 7 citedOpen Access
Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”
Molecular Psychiatry·2024· 1 cited
Review for "Dipyridamole Ameliorates Memory Impairment and Increases Hippocampal Calbindin Expression in Niemann Pick &lt;scp&gt;C1&lt;/scp&gt; Mice"
2024
Review for "Dipyridamole Ameliorates Memory Impairment and Increases Hippocampal Calbindin Expression in Niemann Pick &lt;scp&gt;C1&lt;/scp&gt; Mice"
2024
Amyloid-beta pathology–induced nanoscale synaptic disruption: the case of the GABAB–GIRK assembly
Neural Regeneration Research·2024· 1 citedOpen Access
Analysis of the reasons for consultation in psychiatric emergency triage
European Psychiatry·2024Open Access
Humanized dopamine D <sub>4.7</sub> receptor male mice display risk‐taking behavior and deficits of social recognition and working memory in light/dark‐dependent manner
Journal of Neuroscience Research·2024· 2 citedOpen Access
Author response for "Humanized dopamine D&lt;sub&gt;4.7&lt;/sub&gt; receptor male mice display risk‐taking behavior and deficits of social recognition and working memory in light/dark‐dependent manner"
2024
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone
Molecular Psychiatry·2023· 23 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Rafael Franco(23), Kjell Fuxé(22), Vicent Casadó(15), Carme Lluı́s(14), Francisco Ciruela(11), Steven R. Goldberg(11), Enric I. Canela(11), Luigi F. Agnati(10), Josefa Mallol(8), Amina S. Woods(8), Patrizia Popoli(7), Meritxell Canals(7), Carmen Lluís(6), Daniel Marcellino(6), Nora D. Volkow(6), Antoni Cortés(5), Bertil B. Fredholm(4), Javier Burgueño(4), Rodrigo A. Cunha(4), Maria Torvinen(4)